Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Iran says it has received US response to its latest talks offer
Israeli military urge southern Lebanon residents to evacuate
Russia's Primorsk port hit as Ukraine launches wave of drone strikes
Israel court extends detention of Gaza flotilla activists
